Skip to content

Abnormal Urinary Inosine Level C5936792

Published: July 22, 2026Updated: August 20, 2026

When inosine appears in abnormal amounts in urine, it may point to genetic or metabolic conditions affecting how the body processes nucleotides.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Asymptomatic

(metabolic)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Changes in urine color

(metabolic)

Fatigue

(metabolic)

Back pain

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Nucleoside-modified diet

Dietary modifications reducing intake of nucleoside-rich foods and beverages that can be metabolized to inosine and related purine compounds, helping normalize urinary inosine excretion.

dietary
3

Optimized hydration protocol

Implementing a structured hydration regimen to maintain adequate urine flow, promoting dilution of urinary purine metabolites including inosine and its derivatives.

lifestyle

Additional treatment options

Metabolic workup and specialist referral

Comprehensive evaluation including genetic testing and referral to metabolic disorders specialist to identify underlying causes of abnormal inosine excretion and guide targeted treatment.

monitoring

Enzyme modulation therapy

When indicated, pharmacological agents that modulate purine metabolism enzymes may be prescribed to reduce excessive inosine production and subsequent urinary excretion.

medication

Nutritional supplementation review

Review and adjustment of current vitamin and mineral supplements, particularly those containing purine precursors, to minimize contribution to abnormal inosine metabolism.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Urinary Inosine Level C5936792?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Abnormal Urinary Inosine Level C5936792. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy